Cargando…
Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery
The blood-brain barrier (BBB) presents a barrier for circulating factors, but simultaneously challenges drug delivery. How the BBB is altered in Alzheimer disease (AD) is not fully understood. To facilitate this analysis, we derived brain endothelial cells (iBECs) from human induced pluripotent stem...
Autores principales: | Oikari, Lotta E., Pandit, Rucha, Stewart, Romal, Cuní-López, Carla, Quek, Hazel, Sutharsan, Ratneswary, Rantanen, Laura M., Oksanen, Minna, Lehtonen, Sarka, de Boer, Carmela Maria, Polo, Jose M., Götz, Jürgen, Koistinaho, Jari, White, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220857/ https://www.ncbi.nlm.nih.gov/pubmed/32275861 http://dx.doi.org/10.1016/j.stemcr.2020.03.011 |
Ejemplares similares
-
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
por: Oksanen, Minna, et al.
Publicado: (2019) -
Recent Advances in Microglia Modelling to Address Translational Outcomes in Neurodegenerative Diseases
por: Cuní-López, Carla, et al.
Publicado: (2022) -
An Alzheimer’s Disease Patient-Derived Olfactory Stem Cell Model Identifies Gene Expression Changes Associated with Cognition
por: Rantanen, Laura M., et al.
Publicado: (2022) -
Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012) -
Microglial amyloid beta clearance is driven by PIEZO1 channels
por: Jäntti, Henna, et al.
Publicado: (2022)